SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources

Satoshi Kuwamoto, Michiko Matsushita, Kenichi Takeda, Natsumi Tanaka, Yukari Endo, Akira Yamasaki, Kenichi Kohashi, Yoshinao Oda, Yasushi Horie

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

SMARCA4-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging. Here we report a case of this tumor where the diagnosis was established using limited samples and resources. A woman in her early 30s developed two intrathoracic masses. Biopsies for these lesions showed sheets of undifferentiated round/rhabdoid cells that retained SMARCB1 expression. Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells. Subsequent Sanger sequencing identified a nonsense c.1546A>T (p.516Lys>Ter) mutation in SMARCA4 and confirmed the diagnosis. Our case highlighted clinicopathological correlation and rational use of tissue sections for immunohistochemistry may enable to diagnose this tumor even when only limited samples are available. Recognition of this new entity is important for further understanding of the disease and the future development of specific therapies.

Original languageEnglish
Pages (from-to)92-97
Number of pages6
JournalHuman Pathology
Volume70
DOIs
Publication statusPublished - Dec 2017

Fingerprint

Sarcoma
Thorax
Neoplasms
Immunohistochemistry
Biopsy
Mutation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

SMARCA4-deficient thoracic sarcoma : report of a case and insights into how to reach the diagnosis using limited samples and resources. / Kuwamoto, Satoshi; Matsushita, Michiko; Takeda, Kenichi; Tanaka, Natsumi; Endo, Yukari; Yamasaki, Akira; Kohashi, Kenichi; Oda, Yoshinao; Horie, Yasushi.

In: Human Pathology, Vol. 70, 12.2017, p. 92-97.

Research output: Contribution to journalArticle

Kuwamoto, Satoshi ; Matsushita, Michiko ; Takeda, Kenichi ; Tanaka, Natsumi ; Endo, Yukari ; Yamasaki, Akira ; Kohashi, Kenichi ; Oda, Yoshinao ; Horie, Yasushi. / SMARCA4-deficient thoracic sarcoma : report of a case and insights into how to reach the diagnosis using limited samples and resources. In: Human Pathology. 2017 ; Vol. 70. pp. 92-97.
@article{519adf07507642c88e70c7795e2d465b,
title = "SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources",
abstract = "SMARCA4-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging. Here we report a case of this tumor where the diagnosis was established using limited samples and resources. A woman in her early 30s developed two intrathoracic masses. Biopsies for these lesions showed sheets of undifferentiated round/rhabdoid cells that retained SMARCB1 expression. Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells. Subsequent Sanger sequencing identified a nonsense c.1546A>T (p.516Lys>Ter) mutation in SMARCA4 and confirmed the diagnosis. Our case highlighted clinicopathological correlation and rational use of tissue sections for immunohistochemistry may enable to diagnose this tumor even when only limited samples are available. Recognition of this new entity is important for further understanding of the disease and the future development of specific therapies.",
author = "Satoshi Kuwamoto and Michiko Matsushita and Kenichi Takeda and Natsumi Tanaka and Yukari Endo and Akira Yamasaki and Kenichi Kohashi and Yoshinao Oda and Yasushi Horie",
year = "2017",
month = "12",
doi = "10.1016/j.humpath.2017.05.024",
language = "English",
volume = "70",
pages = "92--97",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - SMARCA4-deficient thoracic sarcoma

T2 - report of a case and insights into how to reach the diagnosis using limited samples and resources

AU - Kuwamoto, Satoshi

AU - Matsushita, Michiko

AU - Takeda, Kenichi

AU - Tanaka, Natsumi

AU - Endo, Yukari

AU - Yamasaki, Akira

AU - Kohashi, Kenichi

AU - Oda, Yoshinao

AU - Horie, Yasushi

PY - 2017/12

Y1 - 2017/12

N2 - SMARCA4-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging. Here we report a case of this tumor where the diagnosis was established using limited samples and resources. A woman in her early 30s developed two intrathoracic masses. Biopsies for these lesions showed sheets of undifferentiated round/rhabdoid cells that retained SMARCB1 expression. Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells. Subsequent Sanger sequencing identified a nonsense c.1546A>T (p.516Lys>Ter) mutation in SMARCA4 and confirmed the diagnosis. Our case highlighted clinicopathological correlation and rational use of tissue sections for immunohistochemistry may enable to diagnose this tumor even when only limited samples are available. Recognition of this new entity is important for further understanding of the disease and the future development of specific therapies.

AB - SMARCA4-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging. Here we report a case of this tumor where the diagnosis was established using limited samples and resources. A woman in her early 30s developed two intrathoracic masses. Biopsies for these lesions showed sheets of undifferentiated round/rhabdoid cells that retained SMARCB1 expression. Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells. Subsequent Sanger sequencing identified a nonsense c.1546A>T (p.516Lys>Ter) mutation in SMARCA4 and confirmed the diagnosis. Our case highlighted clinicopathological correlation and rational use of tissue sections for immunohistochemistry may enable to diagnose this tumor even when only limited samples are available. Recognition of this new entity is important for further understanding of the disease and the future development of specific therapies.

UR - http://www.scopus.com/inward/record.url?scp=85037105224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037105224&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2017.05.024

DO - 10.1016/j.humpath.2017.05.024

M3 - Article

C2 - 28601660

AN - SCOPUS:85037105224

VL - 70

SP - 92

EP - 97

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

ER -